Pattern of metastatic deposit in recurrent prostate cancer: a whole-body MRI-based assessment of lesion distribution and effect of primary treatment
- 108 Downloads
It is generally accepted that when metastases develop in a patient with biochemical recurrence of prostate cancer (PCa), they follow a centrifuge pattern of seeding from the pelvis and that most patients enter the disease as oligometastatic. In this study, we used whole-body magnetic resonance imaging (WB-MRI) to assess the anatomical distribution of oligo- and polymetastatic disease and the impact of the initial treatment on this distribution in patients.
Materials and methods
WB-MRI examinations of patients with a rising prostate-specific antigen (PSA) after radical treatment by surgery or/and radiotherapy were analyzed for disease recurrence. The patients were separated into three groups, based on the primary treatment: patients treated by radical prostatectomy without radiotherapy and with/without lymph node dissection (RP), patients treated only by radiotherapy or hormono-radiotherapy (RT) and patients treated with radical prostatectomy and adjuvant or salvage radiotherapy (RP + RT). Patients with ≤ 5 bone or/and node metastases were considered oligometastatic. Regional distributions of bone and lymph nodes metastases were reported using anatomical diagrams. Univariate and multivariable logistic regressions were performed to identify prognostic factors of relapse.
The primary treatment (RP, RT, RP + RT), Gleason score, PSA at relapse, time between first diagnosis and recurrence did not influence the metastatic status (oligo vs. polymetastatic). Oligometastatic patients showed different distribution of bone metastases compared to the polymetastatic ones and the distribution of the oligometastatic disease was not influenced by the primary treatment.
In this WB-MRI-based study, there was no evidence that the primary treatment influenced the metastatic status of the patient or the distribution of the oligometastatic disease.
KeywordsWhole-body magnetic resonance imaging Whole-body MRI Oligometastatic prostate cancer Prostate cancer Recurrence Recurrent prostate cancer Primary treatment Metastasis distribution
VP, NM, JVD, SVN, BT, FEL: protocol/project development, data collection or management, data analysis, manuscript writing/editing. PT: data collection or management. MH: drawings
Compliance with ethical standards
Conflict of interest
No conflicts of interest.
- 14.Mehta CR, Patel NR (1983) A network algorithm for performing Fisher’s exact test in r c contingency tables. J Am Stat Assoc 78:427–434Google Scholar
- 16.Pampel FC (2000) Logistic regression: a primer. Quantitative applications in the social sciences. Thousand oaks. Sage Publications, CaliforniaGoogle Scholar
- 28.Richard PJ, Rengan R (2016) Oligometastatic non-small-cell lung cancer: current treatment strategies. Lung Cancer (Auckl) 7:129–140Google Scholar
- 33.Padhani AR et al (2017) METastasis reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer. Eur Urol 71(1):81–92PubMedPubMedCentralGoogle Scholar